(PRWEB) November 07, 2013
The Corporate Whistleblower Center says, "Pharmacies are prohibited by law from dispensing Schedule II narcotics, which have the highest potential for abuse of any prescription drug, without a valid prescription from a physician. These types of practices not only put patients at extreme risk, they also cost Medicare millions of dollars each year. Potential whistleblowers should contact us at 866-714-6466 if they have proof expensive prescription drugs are being handed out without a doctor’s approval and signature at a nursing home, a skilled nursing facility, or a rehab center.” http://CorporateWhistleblowerCenter.Com
The Corporate Whistleblower Center believes drugs being dispensed without a prescription is a very widespread problem in nursing homes, rehab facilities, and long term care centers. For example, the Department of Justice recently reported* that PharMerica, a long-term care pharmacy that dispenses drugs to residents of long term-care facilities and nursing homes, is being sued by the government for allegedly dispensing Schedule II narcotics without a written prescription from a medical doctor. As a result, the suit alleges that PharMerica knowingly caused false claims to be submitted to Medicare for the drugs. This is in direct violation of the False Claims Act as well as the Controlled Substances Act.
The Corporate Whistleblower Center will assist potential whistleblowers with compiling their information and putting them in contact with elite whistleblower attorneys. There only caveat is the wrongdoing must involve amounts over a million dollars. For more information, potential whistleblowers are encouraged to contact the Corporate Whistleblower Cwnter anytime at 866-714-6466. http://corporatewhistleblowercenter.com.
Simple rules for a whistleblower from the Corporate Whistleblower Center:
Any type of insider or employee who possesses significant proof of their employer or a government contractor defrauding the federal government is encouraged to contact to Corporate Whistleblower Center anytime at 866-714-6466 or via their web site at http://CorporateWhistleBlowerCenter.Com.
For attribution purposes please review the August 2013 press release from the United States Department of Justice:http://www.justice.gov/opa/pr/2013/August/13-civ-903.html
*Case number: The lawsuit is captioned U.S. ex rel. Denk v. PharMerica Corporation, Case No. 09-cv-720